低分子肝素钙联合辛伐他汀治疗心绞痛的临床疗效分析  

Analysis the Clinical Curative Effect of Low Molecular Heparin Combine With Simvastatin in Treatment of Angina

作　　者：夏东亚[1] 郭好战 李红员 

机构地区：[1]河南省永城市人民医院心内科,476600

出　　处：《中国继续医学教育》2015年第26期147-148,共2页China Continuing Medical Education

摘　　要：目的：分析低分子肝素钙和辛伐他汀联合治疗心绞痛疗效。方法回顾性分析2012年12月～2014年12月本院89例不稳定型的心绞痛患者临床资料，按不同治疗方案分为两组，对照组43例行常规治疗，研究组46例在其基础上行低分子肝素钙和辛伐他汀联合治疗，观察两组疗效及心功能的参数情况。结果对照组总有效率76.7%低于研究组95.7%，P＜0.05，差异具有统计学意义。结论心绞痛给予低分子肝素钙和辛伐他汀联合治疗的疗效显著。Objective Analysis of low molecular weight heparin and simvastatin treatment of angina pectoris.MethodsRetrospective selected 89 cases with court of unstable angina from December 2012 to December 2014 clinical data, according to the different treatment options are divided into two groups, the control group of 43 case adopt routine conventional treatment, 46 cases of the study group at its base upward low molecular weight heparin and simvastatin combination therapy, compared the efifcacy of the two groups was observed parameters and cardiac function.Results The control group total efifciency was 76.7% lower than the study group 95.7%,P〈0.05, had difference statistically signiifcance.Conclusion Angina to low molecular weight heparin and simvastatin combination therapy a signiifcant effect.

关 键 词：辛伐他汀 心绞痛 疗效 

分 类 号：R541[医药卫生—心血管疾病]